Rouchelle J. Mireles

DIFFERENTIAL INTERACTION OF HMG-CoA REDUCTASE INHIBITORS WITH ABCB1, ABCC2, AND OATP1B1

J. Xu, Cuiping Chen, Jian Lin, 2004 .

DIFFERENTIAL INTERACTION OF 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE INHIBITORS WITH ABCB1, ABCC2, AND OATP1B1

J. Xu, T. Smolarek, Jinghai J Xu, 2005, Drug Metabolism and Disposition.

Role of hepatic transporters in the disposition and hepatotoxicity of a HER2 tyrosine kinase inhibitor CP-724,714.

Bo Feng, David B Duignan, D. B. Duignan, 2009, Toxicological sciences : an official journal of the Society of Toxicology.

Inhibition of hepatobiliary transport as a predictive method for clinical hepatotoxicity of nefazodone.

A. Kalgutkar, S. Strom, A. Mutlib, 2006, Toxicological sciences : an official journal of the Society of Toxicology.

Metabolism and transporter-mediated drug-drug interactions of the endothelin-A receptor antagonist CI-1034.

J. Sahi, S. D. de Morais, Xianxian Zheng, 2006, Chemico-biological interactions.

Role of Transporters in the Disposition of the Selective Phosphodiesterase-4 Inhibitor (+)-2-[4-({[2-(Benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic Acid in Rat and Human

Bo Feng, David B Duignan, Sabrina X Zhao, 2007, Drug Metabolism and Disposition.

In Vitro P-glycoprotein Assays to Predict the in Vivo Interactions of P-glycoprotein with Drugs in the Central Nervous System

Bo Feng, John S Janiszewski, S. D. de Morais, 2008, Drug Metabolism and Disposition.

Inhibition of hepatobiliary transport as a predictive method for clinical hepatotoxicity of nefazodone.

A. Kalgutkar, S. Strom, A. Mutlib, 2006, Toxicological sciences : an official journal of the Society of Toxicology.

Role of Transporters in the Disposition of the Selective Phosphodiesterase-4 Inhibitor (+)-2-[4-({[2-(Benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic Acid in Rat and Human

A. Kalgutkar, B. Feng, E. Choo, 2007, Drug Metabolism and Disposition.